comparemela.com

Latest Breaking News On - India formulations - Page 5 : comparemela.com

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab .

India
Glenmark-pharma
Alok-malik
Glenmark-pharmaceuticals-ltd-on
Glenmark-pharmaceuticals-executive-vice
Pharmaceuticals-ltd
Pharmaceuticals-executive-vice-president
India-formulations

Trastuzumab price: Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab . It is now priced at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier.

India
Alok-malik
Glenmark-pharmaceuticals-ltd-on
Glenmark-pharmaceuticals-executive-vice
Pharmaceuticals-ltd
Pharmaceuticals-executive-vice-president
India-formulations

Glenmark Pharma slashes breast cancer drug price by 70% - The Hindu BusinessLine

Glenmark Pharma slashes breast cancer drug price by 70% - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

India
Glenmark-pharma
Alok-malik
Glenmark-pharmaceuticals
Facebook
Twitter
Linkedin
Executive-vice-president
India-formulations

The Rise of The Suncare

The Indian sunscreen market is among the fastest growing in the skincare market, prompting many brands and startups to make a foray into the category, , Magazine 03 June 2023

Hindustan
India-general
India
Shailey-mehrotra
Priyanka-sachdeva
Alok-malik
Mohit-yadav
Prakher-mathur
Estee-lauder
Glenmark-pharmaceuticals
Statista-market-insights
Hindustan-unilever

Lower API costs should start benefiting now, to lend comfort on FY23-25 margin expansion

Analysts at IIFL Securities have analyzed import pricing for 16 key APIs/KSMs imported into India. This study shows that API import costs (weighted average) have declined marginally by 2% QoQ in Q1CY23, after having corrected 8% QoQ and 6% QoQ in Q4CY22 and Q3CY22 respectively from the peaks seen in Q2CY22.

India
China
Apis-ksms
Cipla
Pricing-index
Pricing-index
While-pen-g
India-formulations

vimarsana © 2020. All Rights Reserved.